Last --
Change Today 0.00 / 0.00%
Volume 0.0
4523 On Other Exchanges
Symbol
Exchange
4523 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Yutaka Tsuchiya

Representative Corporate Officer, Eisai Co., Ltd.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

----

Background*

Mr. Yutaka Tsuchiya serves as a Representative Corporate Officer at Eisai Co., Ltd. Mr. Tsuchiya served as Deputy President and Marketing Authorization Supervisor General of Global Product Emergency Management for Healthcare Policy - Chief Executive Officer's special mission at Eisai Co. Ltd. Mr. Tsuchiya served as an Executive Vice President of Eisai Co. Ltd. and served as its Executive Vice President of Corporate Regulatory Compliance, Quality Assurance & Public Affairs. ...

Read Full Background

Corporate Headquarters*

4-6-10, Koishikawa
Tokyo, -- 112-8088

Japan

Phone: 81 3 3817 3700
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4523:JP ¥4,720.50 JPY +5.50

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael W. Bonney B.A.Chief Executive Officer and Director
Cubist Pharmaceuticals Inc.
$750.0K
Carolyn J. Logan Chief Executive Officer, President and Director
Salix Pharmaceuticals Ltd.
$867.5K
Gyo Sagara Chief Executive Officer, President and Representative Director
Ono Pharmaceutical Co., Ltd.
--
Akira Kurokawa President, Chief Executive Officer, Director, Member of Executive Compensation Committee, Member of Nominating Committee and Member of Corporate Strategy Committee
Santen Pharmaceutical Co. Ltd.
--
Eduardo Javier Sanchiz Yrazu Chief Executive Officer, Chief Executive of Corporate Development & Finance, Executive Director, Member of Management Board and Member of Compliance Committee
Almirall, S.A.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EISAI CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.